A Study of Istradefylline (KW-6002) in Treating Patients With Parkinson's Disease on Levodopa
NCT00199420
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
580
Enrollment
INDUSTRY
Sponsor class
Conditions
Parkinson's Disease
Interventions
DRUG:
Istradefylline (KW-6002)
Sponsor
Kyowa Kirin, Inc.